Jiangsu Hengrui Eyes $2 Billion Hong Kong IPO

Jiangsu Hengrui Pharmaceuticals Co. plans a Hong Kong listing to potentially raise $2 billion. Stay updated on this major pharmaceutical IPO.

A sleek and modern illustration of a bustling Hong Kong skyline, with dynamic stock market graphs su
Jiangsu Hengrui Eyes $2 Billion Hong Kong IPO

Jiangsu Hengrui Pharmaceuticals Co. is planning a Hong Kong listing that could raise at least $2 billion.

Source